RxMx has already built and deployed — using InterSystems' database — an automated patient monitoring system for complex medicines that require ongoing laboratory testing for potential adverse effects.
The system detects at-risk test results and notifies or provides reminders to doctors, nurses and patients via emails, texts and mobile apps.
RxMx co-founder Associate Professor Sean Riminton said the company will migrate to InterSystems Iris for Health data platform for healthcare, to help it adapt to a rapidly changing environment.
"As RxMx goes from strength to strength, the volume of data that we collect, analyse and report increases dramatically. We therefore need adaptability from our core technology vendor to be able to rapidly recruit new sources of information into our network."
RxMx software development manager Ben Rhodes said "We are working towards continuous deployment and we know that InterSystems Iris for Health can facilitate that with support for container technology.
"As we scale up to support multiple new medications in markets such as the US and Europe, we may have to integrate with 10 or more different laboratories and vendors, each providing real-time data feeds to a single RxMx platform."
He added "With InterSystems, RxMx never experience issues with the database. The system just runs and the performance will scale to whatever we need. It is important to know that InterSystems is there to make it work, and will always send the right people to help us should we need them."
"With clinically proven technology solutions that improve patient safety and which are deployed around the world, RxMx has achieved an enormous amount in a very short time," said InterSystems Australia and Greater China country manager Luciano Brustia.
"With InterSystems Iris for Health, we look forward to partnering with RxMx to meet whatever technology challenges lie ahead."